Ruby Casareno
Nessuna posizione attualmente
Profilo
Ruby Casareno ricopre la posizione di vicepresidente delle operazioni tecniche alla Allakos, Inc. La dott.ssa Casareno ha conseguito una laurea presso l'Università delle Filippine e un dottorato presso la Ohio State University.
Precedenti posizioni note di Ruby Casareno
| Società | Posizione | Fine |
|---|---|---|
| ALLAKOS INC. | Chief Tech/Sci/R&D Officer | 01/08/2022 |
| ONCOMED PHARMACEUTICALS INC | Corporate Officer/Principal | - |
| PORTOLA PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Formazione di Ruby Casareno
| The Ohio State University | Doctorate Degree |
| University of the Philippines | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ALLAKOS INC. | Health Technology |
| Aziende private | 2 |
|---|---|
OncoMed Pharmaceuticals, Inc.
 OncoMed Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OncoMed Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which focuses on discovering and developing novel therapeutics for cancer's growth, resistance, recurrence and metastasis. The company was founded by Michael F. Clarke and Max Wicha in August 2004 and is headquartered in Redwood City, CA. | Health Technology |
Portola Pharmaceuticals LLC
 Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Portola Pharmaceuticals, Inc. engaged in the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders, and inflammation. It offers Andexxa and Bevyxxa medicines. The company was founded by Charles J. Homcy and David R. Philips on September 2, 2003 and is headquartered in South San Francisco, CA. | Health Technology |
- Borsa valori
- Insiders
- Ruby Casareno
